RU2389477C2 - Способы лечения эндобронхиальных заболеваний - Google Patents

Способы лечения эндобронхиальных заболеваний Download PDF

Info

Publication number
RU2389477C2
RU2389477C2 RU2007101906/14A RU2007101906A RU2389477C2 RU 2389477 C2 RU2389477 C2 RU 2389477C2 RU 2007101906/14 A RU2007101906/14 A RU 2007101906/14A RU 2007101906 A RU2007101906 A RU 2007101906A RU 2389477 C2 RU2389477 C2 RU 2389477C2
Authority
RU
Russia
Prior art keywords
dose
tobramycin
subjects
tpi
treatment
Prior art date
Application number
RU2007101906/14A
Other languages
English (en)
Russian (ru)
Other versions
RU2007101906A (ru
Inventor
Питер ЧЕЛЛОНЕР (US)
Питер ЧЕЛЛОНЕР
Карлос РОДРИГЕС (US)
Карлос РОДРИГЕС
Томас Э. ТАРАРА (US)
Томас Э. ТАРАРА
Джон Д. ЛОРД (US)
Джон Д. ЛОРД
Эмил САМАРА (US)
Эмил САМАРА
Original Assignee
Новартис Ваксинз Энд Дайагностикс Инк.
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новартис Ваксинз Энд Дайагностикс Инк., Новартис Аг filed Critical Новартис Ваксинз Энд Дайагностикс Инк.
Publication of RU2007101906A publication Critical patent/RU2007101906A/ru
Application granted granted Critical
Publication of RU2389477C2 publication Critical patent/RU2389477C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2007101906/14A 2004-06-18 2005-06-20 Способы лечения эндобронхиальных заболеваний RU2389477C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58084804P 2004-06-18 2004-06-18
US60/580,848 2004-06-18

Publications (2)

Publication Number Publication Date
RU2007101906A RU2007101906A (ru) 2008-07-27
RU2389477C2 true RU2389477C2 (ru) 2010-05-20

Family

ID=35782127

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007101906/14A RU2389477C2 (ru) 2004-06-18 2005-06-20 Способы лечения эндобронхиальных заболеваний

Country Status (25)

Country Link
US (3) US20080214481A1 (enExample)
EP (1) EP1765288B1 (enExample)
JP (3) JP2008503500A (enExample)
KR (2) KR20070026604A (enExample)
CN (1) CN101014320B (enExample)
AU (1) AU2005258078B2 (enExample)
BR (1) BRPI0512146A (enExample)
CA (1) CA2570976C (enExample)
DK (1) DK1765288T3 (enExample)
EC (1) ECSP077182A (enExample)
ES (1) ES2399279T3 (enExample)
HR (1) HRP20130076T1 (enExample)
IL (1) IL179873A (enExample)
MA (1) MA28740B1 (enExample)
MX (1) MXPA06014567A (enExample)
NO (1) NO338799B1 (enExample)
NZ (1) NZ552047A (enExample)
PL (1) PL1765288T3 (enExample)
PT (1) PT1765288E (enExample)
RU (1) RU2389477C2 (enExample)
SG (1) SG153833A1 (enExample)
SI (1) SI1765288T1 (enExample)
TN (1) TNSN06420A1 (enExample)
WO (1) WO2006002178A1 (enExample)
ZA (1) ZA200700420B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003053411A1 (en) 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
USD902408S1 (en) 2003-11-05 2020-11-17 Abbott Diabetes Care Inc. Analyte sensor control unit
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US7883464B2 (en) 2005-09-30 2011-02-08 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
CA2665764C (en) 2006-10-11 2015-05-26 Laboratoires Smb S.A. Pharmaceutical anti-infective composition for inhalation
EP1938822A1 (en) * 2006-12-21 2008-07-02 Novartis AG Combination therapy for the treatment of airways disease
KR101621986B1 (ko) * 2008-05-15 2016-05-17 노파르티스 아게 플루오로퀴놀론의 폐 전달
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
TWI792140B (zh) * 2009-05-29 2023-02-11 美商沛爾醫療股份有限公司 用於經由呼吸道遞送二或更多種活性藥劑的組成物、方法與系統
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
CN102473276B (zh) 2009-08-31 2016-04-13 雅培糖尿病护理公司 医疗装置及方法
CA2784207C (en) * 2009-12-14 2018-06-05 Chiesi Farmaceutici S.P.A. Antibiotic microparticles for inhalation
BRPI1105778A2 (pt) 2010-03-24 2016-05-03 Abbott Diabetes Care Inc "insersores de dispositivo médico e processos de inserção e uso de dispositivos médicos"
US11064921B2 (en) 2010-06-29 2021-07-20 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9572774B2 (en) 2011-05-19 2017-02-21 Savara Inc. Dry powder vancomycin compositions and associated methods
US8826904B2 (en) 2011-07-12 2014-09-09 Cardeas Pharma Corporation Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
BR112014000275A2 (pt) 2011-07-12 2017-04-18 Cardeas Pharma Inc formulações aperfeiçoadas de combinações de aminoglicosídeo e fosfomicina e métodos e sistemas para o tratamento de pneumonia associada à ventilação mecânica (pavm) e traqueobronquite associada à ventilação mecânica (vat)
WO2013090215A2 (en) 2011-12-11 2013-06-20 Abbot Diabetes Care Inc. Analyte sensor devices, connections, and methods
WO2014055456A1 (en) * 2012-10-07 2014-04-10 Abbott Diabetes Care Inc. Medical device insertion indicators
CN102949379B (zh) * 2012-11-14 2014-11-05 中山大学 硫酸奈替米星吸入粉雾剂及其制备方法
SG11201507286QA (en) 2013-03-15 2015-10-29 Pearl Therapeutics Inc Methods and systems for conditioning of particulate crystalline materials
US10674944B2 (en) 2015-05-14 2020-06-09 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
CN110461217B (zh) 2017-01-23 2022-09-16 雅培糖尿病护理公司 用于分析物传感器插入的系统、装置和方法
WO2020163416A1 (en) * 2019-02-05 2020-08-13 Mylan Inc Devices and methods for tobramycin inhalation treatment
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
CA3188510A1 (en) 2020-08-31 2022-03-03 Vivek S. RAO Systems, devices, and methods for analyte sensor insertion
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
SU1335297A1 (ru) * 1984-06-15 1987-09-07 Донецкий медицинский институт им.М.Горького Способ лечени больных хроническими заболевани ми легких
WO2000035461A1 (en) * 1998-12-17 2000-06-22 Pathogenesis Corporation Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic
RU2202340C2 (ru) * 1998-05-27 2003-04-20 Юроселтик С.А. Система доставки лекарства

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2224175B1 (enExample) 1973-04-04 1978-04-14 Isf Spa
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1017153B (it) 1974-07-15 1977-07-20 Isf Spa Apparecchio per inalazioni
SE438261B (sv) 1981-07-08 1985-04-15 Draco Ab Anvendning i dosinhalator av ett perforerat membran
GB8314308D0 (en) 1983-05-24 1983-06-29 Matburn Holdings Ltd Medical administration devices
US4805811A (en) 1985-03-29 1989-02-21 Aktiebolaget Draco Dosage device
SE448277B (sv) 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
GB8909891D0 (en) 1989-04-28 1989-06-14 Riker Laboratories Inc Device
IT1243344B (it) 1990-07-16 1994-06-10 Promo Pack Sa Inalatore plurimonodose per medicamenti in polvere
CA2112674C (en) 1991-07-02 2005-10-04 John S. Patton Method and device for delivering aerosolized medicaments
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
US5388572A (en) 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
WO1995031479A1 (en) 1994-05-18 1995-11-23 Inhale Therapeutic Systems, Inc. Methods and compositions for the dry powder formulation of interferons
CZ289029B6 (cs) 1994-09-21 2001-10-17 Inhale Therapeutic Systems Způsob aerosolizace práąku, zejména práąkového léku a zařízení k provádění tohoto způsobu
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
ES2237767T3 (es) 1995-04-14 2005-08-01 Nektar Therapeutics Composiciones farmaceuticas en polvo que tienen una dispersabilidad mejorada.
US5826633A (en) 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
US6586008B1 (en) 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
CA2382821A1 (en) 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
CA2382133C (en) 2000-05-10 2010-11-23 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
PT1320355E (pt) 2001-05-18 2006-08-31 Chiron Corp Sistema para administracao de uma formulacao de tobramicina
DE10131917A1 (de) 2001-07-02 2003-01-23 Infineon Technologies Ag Verfahren zur Erzeugung einer stufenförmigen Struktur auf einem Substrat
ATE509651T1 (de) 2001-11-14 2011-06-15 Novartis Ag Aerosol-vernebler bestehend aus koppelbarem haupt-und endstück
US20030094173A1 (en) 2001-11-14 2003-05-22 Inhale Therapeutic Systems, Inc. Aerosolization device with improved endpiece connection
WO2003053411A1 (en) 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
JP4739672B2 (ja) 2001-12-21 2011-08-03 ネクター セラピューティクス 湿気のバリアを有するカプセルパッケージ
KR20050003416A (ko) 2002-05-07 2005-01-10 넥타르 테라퓨틱스 건조분말 흡입기용 캡슐 및 이의 제조 및 사용 방법
CN1493297A (zh) * 2003-09-13 2004-05-05 南昌弘益科技有限公司 妥布霉素吸入粉雾剂及其制备方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
SU1335297A1 (ru) * 1984-06-15 1987-09-07 Донецкий медицинский институт им.М.Горького Способ лечени больных хроническими заболевани ми легких
RU2202340C2 (ru) * 1998-05-27 2003-04-20 Юроселтик С.А. Система доставки лекарства
WO2000035461A1 (en) * 1998-12-17 2000-06-22 Pathogenesis Corporation Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
СЕМЫКИН С.Ю. Эффективность и безопасность применения ципрофлоксацина при лечении обострений бронхолегочного процесса у детей с муковисцидозом: Автореферат кандидатской диссертации, М., 2002, с 8-11, 23. RAMSEY B.W. et al. «Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group», N Engi J Med. 1999 Jan 7; 340(1):23-30. *

Also Published As

Publication number Publication date
CN101014320B (zh) 2011-05-18
HRP20130076T1 (hr) 2013-03-31
BRPI0512146A (pt) 2008-02-12
MXPA06014567A (es) 2007-07-24
US20110097412A1 (en) 2011-04-28
NO338799B1 (no) 2016-10-24
IL179873A0 (en) 2007-05-15
ZA200700420B (en) 2008-05-28
AU2005258078A1 (en) 2006-01-05
MA28740B1 (fr) 2007-07-02
WO2006002178A1 (en) 2006-01-05
KR20070026604A (ko) 2007-03-08
KR20120131245A (ko) 2012-12-04
TNSN06420A1 (en) 2008-02-22
AU2005258078B2 (en) 2010-09-30
CA2570976A1 (en) 2006-01-05
PT1765288E (pt) 2013-01-29
IL179873A (en) 2014-09-30
JP2012107047A (ja) 2012-06-07
EP1765288A4 (en) 2009-05-13
JP2013056947A (ja) 2013-03-28
CA2570976C (en) 2013-08-13
DK1765288T3 (da) 2013-02-11
NZ552047A (en) 2009-11-27
US20120148641A1 (en) 2012-06-14
SG153833A1 (en) 2009-07-29
EP1765288B1 (en) 2012-11-07
JP2008503500A (ja) 2008-02-07
US8664187B2 (en) 2014-03-04
PL1765288T3 (pl) 2013-04-30
RU2007101906A (ru) 2008-07-27
ES2399279T3 (es) 2013-03-27
CN101014320A (zh) 2007-08-08
NO20070253L (no) 2007-03-13
SI1765288T1 (sl) 2013-02-28
EP1765288A1 (en) 2007-03-28
ECSP077182A (es) 2007-05-30
US20080214481A1 (en) 2008-09-04

Similar Documents

Publication Publication Date Title
RU2389477C2 (ru) Способы лечения эндобронхиальных заболеваний
Geller et al. Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety
Labiris et al. Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications
Eisenberg et al. A comparison of peak sputum tobramycin concentration in patients with cystic fibrosis using jet and ultrasonic nebulizer systems
Wilmott et al. Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations.
Hatipoglu et al. Pharmacokinetics and pharmacodynamics of high doses of inhaled dry powder drugs
JP2017530993A (ja) 配合物の安定性を高めるために噴霧乾燥によって得られる少なくとも１種の乾燥粉末を含む組成物
Shrewsbury et al. Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma
US20120213707A1 (en) Riboflavin Based Aerosol and Use as Placebo in Trials
Debnath et al. Status of inhalable antimicrobial agents for lung infection: progress and prospects
US7973029B2 (en) Inhaled aztreonam lysine for the treatment of deficits in health-related quality-of-life in lung diseases
Stout et al. Local treatment of respiratory infections with antibiotics
Westerman et al. Aerosolization of tobramycin (TOBI®) with the PARI LC PLUS® reusable nebulizer: which compressor to use? Comparison of the CR60® to the PortaNeb® compressor
Balducci et al. Drug delivery strategies for pulmonary administration of antibiotics
WO2002002126A1 (en) Medicaments containing dextrin for treating respiratory disorders such as cystic fibrosis
Rubin Mucoactive agents for the treatment of cough
WO2022166724A1 (zh) 一种福多司坦吸入用溶液制剂及其制备方法和用途
Bush et al. 8. NEBULIZERS IN CYSTIC FIBROSIS AND NON-CF BRONCHIECTASIS IN CHILDREN AND ADULTS: THERAPIES
Labiris Inhaled aminoglycosides for the treatment of chronic respiratory Pseudomonas aeruginosa infections in cystic fibrosis
Westerman et al. 3Aerosolisation of tobramycin (TOBI®)

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20110920